TRIUMPH-1 trajectory (80 weeks + extension): Week 80: 28.3% average weight loss (2,339 patients) 104-week extension (BMI 35 subgroup): 30.3% average weight loss Weight loss does not plateau at 80 weeks it continues in longer treatment The TRIUMPH-1 104-week extension is the most important long-term efficacy signal we have
All treatments are customized based on a consultation with a medical provider
Patients who inject while dehydrated report symptom severity 4050% higher than those who hydrate adequately
When the key (agonist) binds to the lock (receptor), it opens the door (activates the receptor) to produce a specific effect
Dr Hoe Ying Min, medical director at Bay Aesthetics Clinic And Medispa, said she has observed a rise in interest in weight loss medications
This design choice introduces potential bias, particularly for subjective outcomes, but it reflects the practical reality that these treatments have different injection devices and titration schedules that would make blinding extremely difficult